Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hongai Tongluo decoction is a traditional Chinese medicine (TCM) herbal formula used in clinical practice, particularly in China. It is being investigated for its potential to alleviate neurotoxicity induced by oxaliplatin chemotherapy in patients with digestive tract tumors such as gastric and colorectal cancer. The formula is typically administered orally and may be combined with other TCM therapies like Du moxibustion. While the precise herbal composition and mechanism of action are not detailed in the available sources, TCM formulas named "Tongluo" generally aim to promote blood circulation, remove blood stasis, and unblock meridians according to TCM theory. These actions are believed to help reduce symptoms related to nerve injury or toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hongai Tongluo decoction.